FDA approves Roche drug for rare autoimmune disorder NMOSD

Text FDA Approved appearing behind ripped brown paper.

The agency approved Enspryng for the disease, which is often misdiagnosed as multiple sclerosis and can cause blindness, muscle weakness and paralysis.